Today, shares of GBS (NASDAQ:GBS) are skyrocketing following news that “the company will start preparation for clinical trials of its rapid SARS-CoV-2 antibody test.” GBS’s antibody test utilizes ...

The number of diagnostic tests used to evaluate biological material has exploded over the last decades. These tests help identify disease, determine treatment and show whether or not a condition is ...

NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at ...

Group B streptococcus (GBS) is a bacteria about 25% of pregnant women carry. It's rare for babies to get GBS disease from their mothers during labor, but it can be very harmful. So healthcare ...

I haven't really talked publicly about this much, but for the past couple years my husband and I have been trying to start a family. It's been a long and difficult path, and I'll share the whole story ...

Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus intrapartum testing for pregnant females Group B Streptococcus (GBS) is the leading cause of ...

Diagnostic test maker Meridian Bioscience (NASDAQ:VIVO) has received regulatory clearance of a molecular diagnostics test for group B streptococcus. The group B strep test is the second in the ...